Literature DB >> 6140670

Transmitter release in tetanus and botulinum A toxin-poisoned mammalian motor endplates and its dependence on nerve stimulation and temperature.

F Dreyer, A Schmitt.   

Abstract

The effects of tetanus toxin (TeTx) and botulinum A toxin (BoTx) on spontaneous and nerve-evoked transmitter release have been compared in mouse hemidiaphragms poisoned in vitro. At 37 degrees C endplates poisoned with either of these agents were characterized by (1) a decrease of miniature endplate potential (m.e.p.p.)-frequency to less than 30/min for TeTx and 3/min for BoTx, (2) reduced mean m.e.p.p.-amplitude and (3) 100% failure to show endplate potentials (e.p.p.s) in response to single nerve stimuli. In addition (4) tetanic nerve stimulation and/or reduction of temperature to about 20 degrees C caused a remarkable increase in the nerve-evoked transmitter release, but did not affect the low frequency of spontaneous m.e.p.p.s. However, several important differences exist between the effects of both toxins. (1) At room temperature even single nerve stimuli could elicit e.p.p.s in BoTx-muscles the failure rate being about 80%. For TeTx the failure was 100%. However, if the nerve was stimulated with higher frequencies (greater than 5 Hz), the probability of quantal release increased, the delay for release from the onset of stimulation being several seconds and similar to that observed at 37 degrees C. (2) TeTx distorted the synchronous release of quanta increasing the distribution of their synaptic delays. BoTx did not influence the time course of the phasic secretion process in response to nerve action potentials. (3) TeTx preferentially blocked the release of spontaneous m.e.p.p.s of large amplitude without affecting the frequency of the small amplitude ones, while BoTx inhibited both the small and large amplitude m.e.p.p.s. The distribution of the amplitudes of the nerve-evoked m.e.p.p.s were similar to those of spontaneous m.e.p.p.s before the blockade with the toxins.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6140670     DOI: 10.1007/bf00656720

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  23 in total

1.  The effect of tetanus toxin at the neuromuscular junction in the goldfish.

Authors:  J Mellanby; P A Thompson
Journal:  J Physiol       Date:  1972-07       Impact factor: 5.182

2.  The effects of tetanus toxin on neuromuscular transmission and on the morphology of motor end-plates in slow and fast skeletal muscle of the mouse.

Authors:  L W Duchen; D A Tonge
Journal:  J Physiol       Date:  1973-01       Impact factor: 5.182

3.  Miniature end-plate potentials at mammalian neuromuscular junctions poisoned by botulinum toxin.

Authors:  N Spitzer
Journal:  Nat New Biol       Date:  1972-05-03

4.  Tetanus toxin, a neuromuscular blocking agent.

Authors:  H E Kaeser; A Saner
Journal:  Nature       Date:  1969-08-23       Impact factor: 49.962

5.  The antagonism between botulinum toxin and calcium in motor nerve terminals.

Authors:  C B Gundersen; B Katz; R Miledi
Journal:  Proc R Soc Lond B Biol Sci       Date:  1982-10-22

6.  Different effects of botulinum A toxin and tetanus toxin on the transmitter releasing process at the mammalian neuromuscular junction.

Authors:  F Dreyer; A Schmitt
Journal:  Neurosci Lett       Date:  1981-11-04       Impact factor: 3.046

7.  Botulinum toxin: mechanism of presynaptic blockade.

Authors:  I Kao; D B Drachman; D L Price
Journal:  Science       Date:  1976-09-24       Impact factor: 47.728

Review 8.  Effects and mechanisms of polypeptide neurotoxins that act presynaptically.

Authors:  B D Howard; C B Gundersen
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

9.  Observations on the action of type A botulinum toxin on frog neuromuscular junctions.

Authors:  D A Boroff; J del Castillo; W H Evoy; R A Steinhardt
Journal:  J Physiol       Date:  1974-07       Impact factor: 5.182

10.  Spontaneous subminature end-plate potentials in mouse diaphragm muscle: evidence for synchronous release.

Authors:  M E Kriebel; F Llados; D R Matteson
Journal:  J Physiol       Date:  1976-11       Impact factor: 5.182

View more
  13 in total

1.  Function Suggests Nano-Structure: Quantitative Structural Support for SNARE-Mediated Pore Formation.

Authors:  Ilan Hammel; Isaac Meilijson
Journal:  Neurotox Res       Date:  2015-09-25       Impact factor: 3.911

2.  Ca2+ or Sr2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin.

Authors:  M Capogna; R A McKinney; V O'Connor; B H Gähwiler; S M Thompson
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

3.  The Relevance of AgRP Neuron-Derived GABA Inputs to POMC Neurons Differs for Spontaneous and Evoked Release.

Authors:  Andrew R Rau; Shane T Hentges
Journal:  J Neurosci       Date:  2017-06-30       Impact factor: 6.167

4.  A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D.

Authors:  J Molgó; L S Siegel; N Tabti; S Thesleff
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

5.  The action of thallium acetate on phasic transmitter release in the mouse neuromuscular junction.

Authors:  H Wiegand; H Lohmann; S V Chandra
Journal:  Arch Toxicol       Date:  1986-04       Impact factor: 5.153

6.  Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain.

Authors:  B Poulain; L Tauc; E A Maisey; J D Wadsworth; P M Mohan; J O Dolly
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Differential effects of various secretagogues on quantal transmitter release from mouse motor nerve terminals treated with botulinum A and tetanus toxin.

Authors:  F Dreyer; F Rosenberg; C Becker; H Bigalke; R Penner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

8.  Protein kinase C and clostridial neurotoxins affect discrete and related steps in the secretory pathway.

Authors:  M A Bittner; R W Holz
Journal:  Cell Mol Neurobiol       Date:  1993-12       Impact factor: 5.046

9.  Responsiveness to botulinum toxin type A in muscles of complex regional pain patients with tonic dystonia.

Authors:  Johanna C M Schilder; J Gert van Dijk; Dirk Dressler; Johannes H T M Koelman; Johan Marinus; Jacobus J van Hilten
Journal:  J Neural Transm (Vienna)       Date:  2014-02-15       Impact factor: 3.575

10.  Clostridial neurotoxins compromise the stability of a low energy SNARE complex mediating NSF activation of synaptic vesicle fusion.

Authors:  L L Pellegrini; V O'Connor; F Lottspeich; H Betz
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.